Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Frontiers Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

Molecular stratification within triple-negative breast cancer subtypes

Triple-negative breast cancer: understanding Wnt signaling in drug resistance, Cancer Cell International

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

Frontiers The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer

Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics - RSC Advances (RSC Publishing) DOI:10.1039/D2RA02005J

Patient-derived xenograft models in cancer therapy: technologies

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors [PeerJ]